Document Detail


Antithrombotic Drug Uses and Deep Intracerebral Hemorrhages in Stroke Patients with Deep Cerebral Microbleeds.
MedLine Citation:
PMID:  22959109     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: It has been suggested that antiplatelet or anticoagulant drugs elevate the rate of intracerebral hemorrhage (ICH) in patients with cerebral microbleeds (MBs). To investigate the mechanism by which antiplatelet drugs or warfarin may contribute to deep ICH occurrences in patients with deep MBs, we prospectively analyzed deep ICH occurrences in 807 consecutive patients (351 females and 456 males; mean age ± standard deviation 69.8 ± 12.0 years) who were admitted to our hospital with strokes. METHODS: Occurrence-free rate curves were generated using the Kaplan-Meier method; deep ICH occurrence-free rates were compared using the log-rank test. The follow-up period was 0.5 to 71 months (mean ± standard deviation 31.6 ± 22.2 months). RESULTS: In patients with deep MBs, the rates (1.0%/year; 6 ICHs in 180 patients) of deep ICH occurrence associated with antiplatelet drugs were not significantly greater than that without the drugs (1.0%/year; 6 ICHs in 167 patients; P = .977). The incidence of deep ICHs associated with warfarin use was not significantly greater than that without warfarin use. CONCLUSIONS: Multivariate analysis revealed that the use of antiplatelet drugs or warfarin did not significantly influence the occurrence of deep ICH in patients with deep MBs. Antiplatelet drugs or warfarin did not significantly elevate the rate of deep ICHs in stroke patients with pre-existing deep MBs.
Authors:
Toshio Imaizumi; Shigeru Inamura; Ikuhide Kohama; Kazuhisa Yoshifuji; Tatsufumi Nomura; Katsuya Komatsu
Related Documents :
24676179 - Patterns of antimicrobial therapy in acute tonsillitis: a cross-sectional hospital-base...
24145529 - Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by leis...
238819 - Studies of the disposition and metabolism of mefloquine hcl (wr 142,490), a quinolineme...
23856399 - Patterns of antituberculous drug resistance in eastern saudi arabia: a 7-year surveilla...
23451879 - Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a...
24090949 - Dopaminergic modulation of motor coordinaton in parkinson's disease.
14746629 - Acute generalized exanthematous pustulosis associated with pseudoephedrine.
17367939 - Asco 2006 highlights: targeted therapy for renal cell carcinoma.
412419 - Drug product advertising and prescribing: a review of the evidence.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-6
Journal Detail:
Title:  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association     Volume:  -     ISSN:  1532-8511     ISO Abbreviation:  J Stroke Cerebrovasc Dis     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111633     Medline TA:  J Stroke Cerebrovasc Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Neurosurgery, Kushiro City General Hospital, Hokkaido, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cerebral Infarction in both Carotid and Vertebrobasilar Territories Associated with a Persistent Pri...
Next Document:  Phase I Study of Intravenous Low-dose Granulocyte Colony-stimulating Factor in Acute and Subacute Is...